Pharmacogenomic Testing to Guide Treatment of Major Depressive Disorder: A Systematic Review

被引：0
|
作者：
Farah Khorassani
Mandy Jermain
Christine Cadiz
机构：
[1] University of California Irvine,Department of Clinical Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences
[2] AbbVie Inc.,undefined
来源：
Current Treatment Options in Psychiatry | 2024年 / 11卷 / 2期
关键词：
Pharmacogenomics; Pharmacogenetics; Pharmacogenetic testing; Antidepressive agents; Depressive disorder; Depression;
D O I：
10.1007/s40501-024-00316-x
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：123 / 140
页数：17
相关论文
共 50 条
  • [11] A systematic review of interventions for treatment resistant major depressive disorder in adolescents
    Boylan, Khrista
    MacQueen, Glenda
    Kirkpatrick, Ryan
    Lee, Jonathan
    Santaguida, Pasqualina L.
    [J]. EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2020, 29 (04) : 433 - 443
  • [12] A systematic review of interventions for treatment resistant major depressive disorder in adolescents
    Khrista Boylan
    Glenda MacQueen
    Ryan Kirkpatrick
    Jonathan Lee
    Pasqualina L. Santaguida
    [J]. European Child & Adolescent Psychiatry, 2020, 29 : 433 - 443
  • [13] Networks of major depressive disorder: A systematic review
    Malgaroli, Matteo
    Calderon, Adam
    Bonanno, George A.
    [J]. CLINICAL PSYCHOLOGY REVIEW, 2021, 85
  • [14] A systematic review of yoga for major depressive disorder
    Cramer, Holger
    Anheyer, Dennis
    Lauche, Romy
    Dobos, Gustav
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2017, 213 : 70 - 77
  • [15] The effect of pharmacogenomic testing on response and remission rates in the acute treatment of major depressive disorder: A meta-analysis
    Rosenblat, Joshua D.
    Lee, Yena
    McIntyre, Roger S.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2018, 241 : 484 - 491
  • [16] SUBPHENOTYPES IN MAJOR DEPRESSIVE DISORDER TO BETTER CHARACTERIZE PHARMACOGENOMIC ANTIDEPRESSANT TREATMENT RESPONSE
    Ahmed, A. T.
    Frye, M. A.
    Rush, A.
    Bobo, W. V.
    Biernacka, J.
    Flavin, D. Hall
    Jenkins, G. D.
    Batzle, A.
    Skime, M. K.
    Wang, L.
    Craighead, W.
    Mayberg, H. S.
    Weinshilboum, R. M.
    Kaddurah-Daouk, R. F.
    Dunlop, B. W.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (S1) : S19 - S20
  • [17] Systematic review of pindolol augmentation of serotonergic antidepressant treatment for major depressive disorder
    Whale, R
    Terao, T
    Cowen, PJ
    Geddes, J
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 : S420 - S420
  • [18] Exercise as an add-on strategy for the treatment of major depressive disorder: a systematic review
    Mura, Gioia
    Moro, Maria Francesca
    Patten, Scott B.
    Carta, Mauro G.
    [J]. CNS SPECTRUMS, 2014, 19 (06) : 496 - 508
  • [19] Zuranolone for treatment of major depressive disorder: a systematic review and meta-analysis
    Ahmad, Abdullah
    Awan, Abdul Rafeh
    Nadeem, Natasha
    Javed, Aamir Shahid
    Farooqi, Mobeen
    Daniyal, Muhammed
    Mumtaz, Hassan
    [J]. FRONTIERS IN NEUROSCIENCE, 2024, 18
  • [20] Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults- A Systematic Review
    Watford, Tessa
    Masood, Naqash
    [J]. CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, 2024, 22 (01) : 2 - 12
12345